Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

NCRI 2018 | Immunotherapeutic landscape for head and neck cancer

Name: Immunotherapeutic landscape for head and neck cancer
Duration: 2 min 36 s

Quynh-Thu Le • 8 Nov 2018

NCRI 2018

Head and Neck Cancer Antibodies Checkpoint Inhibitors

Speaking from the 2018 National Cancer Research Institute (NCRI) Cancer Conference, held in Glasgow, UK, Quynh-Thu Le, MD, from Stanford University, Stanford, CA, discusses the current immunotherapeutic landscape for head and neck cancer. Prof. Le discusses the progress made in the recurrent setting, and highlights investigations now moving into the frontline. She also explains the toxicities to be aware of when using immunotherapy in this malignancy.